The journal Archives of Iranian Medicine just published a set of 33 papers about one study.
Academic publishing is dominated by a small number of commercial firms. How can the academy take control of scholarly publishing?
I found job satisfaction and exciting opportunities in supporting other academics - but it's a career path that many don't consider. Try it.
Science|Business has published an exhaustive but unapproved draft Horizon Europe work programme detailing the calls for climate and mobility projects for the next two years and an early draft outlining bioeconomy, food and environment calls.
Intriguing correlation mined from 140,000 papers.
A new paper recommends that the label “statistically significant” be dropped altogether; instead, researchers should describe and justify their decisions about study design and interpretation of the data, including the statistical threshold.
To help manage the shortage, the authorities sent a message that made them untrustworthy.
The SNSF meticulously examines its funding activities. From now on, it will publish these analyses on its data portal. To kick things off, Open Access, ERC grants and women scientists during the pandemic are in focus.
Baby boomers and retirement policies are contributing to overall aging, and the trend is likely to continue.
In order to align incentives with good science, we need to move to a system in which work that is well thought-out, well carried-out, and well communicated – regardless of the ‘story’ it tells – is given the highest reward. Changing what is rewarded will change what is done.
State your main finding in your title, and don't forget to use the word 'but', says Bruce Kirchoff.
Open science is becoming more and more prevalent. Critics, however, think this approach makes it easier to steal somebody else’s ideas.
Swiss Academy of Sciences conference on metrics and assessment.
The Breakthrough Prize Foundation and its founding sponsors today announced the winners of the 10th annual Breakthrough Prizes, awarding a total of $15.75 million to an esteemed group of laureates and early-career scientists.
As public pressure builds for drug companies to make more results available from clinical trials, the industry should not forget that it relies on collective goodwill to test new therapies.
Authors from western, individualist cultures are more likely to use many self-citations than authors from more collectivist cultures.
The push for rapid and open publishing could take off - although financial pressures lie ahead: part 4 in a series on science after the pandemic.
‘Scientific’ eugenics is on the rise, and grabbing a foothold in respected journals. The claim that these theories are a credible part of a general discussion should worry us all.
From pilots to practice, more and more publishers are warming to open peer review.
